Svetlana Mosteoru✓

@SMosteoru

Cardiologist passionate about research

  • Timişoara, România
  • Joined
182 Following215 Followers431 Posts
  1. Svetlana Mosteoru✓@SMosteoru
    Svetlana Mosteoru
    RT @EJPCEiC: ✅Lp(a) at the #AHA congress: no 💊 pharma yet on the HORIZON. So should we still screen it ? Does Knowing Lp(a) Change What We Do? See the debate in #EJPC ⤵️
    050229
  2. Svetlana Mosteoru✓@SMosteoru
    Svetlana Mosteoru
    RT @EJPCEiC: Acute exposure to 🚬 promotes vascular dysfunction, ⬆️ venous CO2, and acute 🧬 damages in healthy 🧑‍🦱👩‍🦱 adults. Explore more insights in the recent #EJPC paper ⤵️ 🔗
    020377
  3. Svetlana Mosteoru✓@SMosteoru
    Svetlana Mosteoru
    RT @EJPCEiC: In patients with coronary heart disease, 150 min/wk of moderate-intensity physical activity was associated with 38% lower all-cause mortality. A dose–response meta-analysis of 176,862 patients highlights the benefits of low-to-moderate activity levels. 🔗
    036010.2K
  4. Svetlana Mosteoru✓@SMosteoru
    Svetlana Mosteoru
    RT @EJPCEiC: 📉 Fewer ischemic events, but more bleeding after heart attack? SWEDEHEART data showed declining CV events but increasing bleeding complications, particularly upper GIS bleeding. Tailored antithrombotic therapy and gastroprotection remain essential. 🔗
    030451
  5. Svetlana Mosteoru✓@SMosteoru
    Svetlana Mosteoru
    RT @EJPCEiC: 🫀Fear of cardiac symptoms may become a barrier to recovery. A systematic review of 26 studies (n=9,628) found heart-focused anxiety in 15–49% of patients with CVD, linked to exercise avoidance and poorer outcomes. 🔗
    0701.3K
  6. Svetlana Mosteoru✓@SMosteoru
    Svetlana Mosteoru
    RT @EJPCEiC: 🤰🫀 Hyperlipidaemia in pregnancy: physiology or cardiovascular risk? A timely review of peripartum lipid changes, maternal & fetal outcomes, treatment options, and key evidence gaps. 🔗
    060416
  7. Svetlana Mosteoru✓@SMosteoru
    Svetlana Mosteoru
    RT @EJPCEiC: Younger age at first diagnosis is strongly associated with lower risk of subsequent events in patients with cerebrovascular disease (stroke) and in women with peripheral artery disease or abdominal aortic aneurysm 📖 @escardio @AboyansV @SilCastelletti
    050344
  8. Svetlana Mosteoru✓@SMosteoru
    Svetlana Mosteoru
    RT @society_eas: Our second event in this year’s EAS Advanced Courses on non-classical risk factors series will take place in Prague, Czech Republic. The application process is now open. Join us to learn about the potential role of non-classical factors including chronic inflammation, metabolic disturbances, gut microbiota, psychosocial stress, and environmental influences in cardiovascular disease risk and progression. Register here:
    020297
  9. Svetlana Mosteoru✓@SMosteoru
    Svetlana Mosteoru
    RT @society_eas: Our EAS Advanced Courses on non-classical risk factors are back! While traditional risk factors such as high blood pressure, elevated cholesterol, smoking, and diabetes are well recognised, emerging evidence highlights the potential role of non-classical factors - including chronic inflammation, metabolic disturbances, gut microbiota, psychosocial stress, and environmental influences - in cardiovascular disease risk and progression. Join us in Athens, Greece, for the first event in the 2026 series, and register now:
    030348
  10. Svetlana Mosteoru✓@SMosteoru
    Svetlana Mosteoru
    RT @Ajar_kocak: An interesting session on the final morning of #ESCCongress 2026 🫀 Residual risk beyond LDL-C: achieving LDL-C targets is only part of the story. Lp(a), persistent inflammation and cardiometabolic risk may help identify the patients who remain at risk — and increasingly provide targets for intervention. Great perspectives on Lp(a), colchicine and GLP-1 therapies presented by great faculty. @escardio @TokgozogluLale @KoKoMaung_ @GalTsaban @SMosteoru #preventivecardiology
    010193
  11. Svetlana Mosteoru✓@SMosteoru
    Svetlana Mosteoru
    RT @Ajar_kocak: 🔥 Hot Line 11 at #ESCCongress 🫀 An important question in our oldest NSTEMI patients: does everyone ≥80 years need routine invasive management? EVAOLD challenges the “one-size-fits-all” approach, evaluating a selective invasive strategy guided by ischemia testing versus systematic coronary angiography. A highly relevant trial for everyday clinical decision-making. @escardio @KoKoMaung_ @GalTsaban @SMosteoru
    020179
  12. Svetlana Mosteoru✓@SMosteoru
    Svetlana Mosteoru
    RT @NIPCIRELAND: Thirty years of #EUROASPIRE! This evening in Munich, @escardio and NIPC mark the 30th anniversary of EUROASPIRE with researchers, national coordinators and clinical teams who have contributed to the programme over three decades. EUROASPIRE video⬇️
    010249
  13. Svetlana Mosteoru✓@SMosteoru
    Svetlana Mosteoru
    RT @slumberbell: Wait… what do ESC Young Professionals Chair @cfcamm & our #ESCMotions teammate @rafavidalperez do in their free time at #ESCCongress? 👀 Practise saving lives, of course! 🫀🙌 We caught them brushing up on their resuscitation skills at the European Resuscitation Council (ERC) CPR workshop station in Hall B1! Want to join the action? 📍Hall B1 📍FREE, 90-minute hands-on BLS & ALS refresher workshops 📍Practise with expert instructors; from high-quality CPR & AED use to teamwork during resuscitation 📍ERC certificate of attendance provided after the congress Still time to join today, 30 August: 🫀BLS: 14:00-15:30 🫀ALS: 16:00-17:30 Places are limited, with final registration on-site on a first-come, first-served basis. Bring your teamwork; & give those lifesaving skills a workout! 💪 Full programme & pre-registration: #ESCMotions #ESCCongress @escardio @corneliacrm @_antocannata @KardiologieHH @DrMarthaGulati @SMosteoru @Massimi78530343 @drmilicaa @jozinetm @Sarah_Moharem
    0501.1K
  14. Svetlana Mosteoru✓@SMosteoru
    Svetlana Mosteoru
    RT @EJPCEiC: Just presented at #ESCCongress 2026 ✅ and simultaneously 📕 in the #EJPC ⤵️ Sport type 🏋‍♂️ 🏃‍♀️‍➡️ 🏊‍♀️ alone does not reliably predict distinct cardiac phenotypes in athletes 📑
    070715